Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

CYTODYN INC (CYDY)

CYDY RSS Feed
Add CYDY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator shallwemaui
Search This Board:
Last Post: 10/31/2014 7:33:14 AM - Followers: 10 - Board type: Free - Posts Today: 0
CYTODYN INC (CYDY.OB) 200 W Devargas Street Suite 1 Santa Fe, NM 87501 Phone: 505-988-5520 Fax: 505-988-5538 Web Site: http://www.cytodyn.com DETAILS Index Membership: N/A Sector: Healthcare Industry: Diagnostic Substances Full Time Employees: 2 BUSINESS SUMMARY CytoDyn, Inc., a development stage biotechnology research company, engages in the discovery and development of a treatment for human immunodeficiency virus. Its treatment bolsters the human immune system by an injection of monoclonal antibodies. The company’s lead drug candidate is Cytolin, a monoclonal antibody that protects CD4 cells from CD8 cells, which prevents the weakening of the immune system. It is also collaborating with another biotech company for the development of drugs for treating neuropsychiatric disorders. CytoDyn is based in Santa Fe, New Mexico. Share Statistics Average Volume (3 month)3: N/A Average Volume (10 day)3: N/A Shares Outstanding: 8.52M Float: N/A % Held by Insiders4: N/A % Held by Institutions4: N/A Shares Short 3: N/A Short Ratio 3: N/A Short % of Float 3: N/A Shares Short (prior month)3: N/A CytoDyn Shares Trading http://biz.yahoo.com/bw/051118/20051118005135.html?.v=1
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CYDY
Current Price
Volume:
Bid Ask Day's Range
Wiki
CYDY News: Statement of Changes in Beneficial Ownership (4) 10/31/2014 05:06:07 PM
CYDY News: Statement of Changes in Beneficial Ownership (4) 10/16/2014 02:09:48 PM
CYDY News: Quarterly Report (10-q) 10/10/2014 04:04:43 PM
CYDY News: Statement of Changes in Beneficial Ownership (4) 10/08/2014 02:18:55 PM
CYDY News: Initial Statement of Beneficial Ownership (3) 10/06/2014 07:36:23 PM
News News Alert: Statement of Changes in Beneficial Ownership (4) 10/31/2014 05:06:07 PM
PostSubject
#449   Well here we are on Halloween and moving sevensisters 10/31/14 07:33:14 AM
#448   CytoDyn requests "end Phase 2b meeting" with FDA Apollo_ 10/13/14 10:52:05 AM
#447   Will the reverse split happen now? Sun devil 10/08/14 03:16:48 PM
#446   Currently recruiting participants, Verified October 2014 Drexel University Apollo_ 10/06/14 02:27:44 PM
#445   Drexel's Jeffery Jacobson Publishes CCR5 Paper This Week Apollo_ 10/04/14 01:02:19 AM
#444   $ Raise, New Board Member - New Listing Apollo_ 10/02/14 11:45:16 AM
#443   The potential to target CCL5/CCR5 in breast cancer Apollo_ 10/01/14 02:03:29 AM
#442   Pretty Good Video on CCR5 Antagonists Apollo_ 09/23/14 09:47:51 PM
#441   Dog WTF are you talking about? This inversor86 09/19/14 03:28:45 PM
#440   So, inversor, you really think the shares wouldn't Dog5277 09/19/14 12:31:34 PM
#439   http://www.investopedia.com/articles/basics/03/030703.asp inversor86 09/18/14 09:35:49 PM
#438   You would have to be crazy to not Dog5277 09/18/14 04:19:54 PM
#437   Shares outstanding is not that same as the inversor86 09/17/14 09:23:13 PM
#436   Untrue on the shares. At the meeting Dog5277 09/17/14 01:54:58 PM
#435   Nader does some strange interviews. inversor86 09/16/14 10:02:18 PM
#434   shares outstanding is around 60 million. inversor86 09/16/14 09:59:15 PM
#433   Big Pharma loves buying appealing small caps like Apollo_ 09/15/14 11:56:18 PM
#432   It was two years ago when ... Apollo_ 09/13/14 12:57:21 AM
#431   According to the meeting, we should now have shallwemaui 09/10/14 12:12:27 PM
#430   Yes, VERY frustrating Dr Jacobson won't budge especially Apollo_ 09/09/14 01:06:39 AM
#429   That's great, but its from 2007. I searching4rainbow 09/08/14 12:26:25 PM
#428   Audio of Dr Jeffrey Jacobson Discussing PRO 140 Apollo_ 09/06/14 11:27:59 PM
#427   Maraviroc is a poor (and toxic) ccr5 antagonist Apollo_ 09/06/14 07:38:21 PM
#426   Maraviroc venus1 09/05/14 05:51:03 PM
#425   Another week gone, but hopefully a week closer! Dog5277 09/05/14 03:19:17 PM
#424   Johns Hopkins researchers discover that FDA-approved HIV drug Apollo_ 09/02/14 11:10:09 PM
#423   Maraviroc may prevent breast cancer from metastasizing, PRO140? Apollo_ 09/02/14 06:13:21 PM
#422   hey dog - just hopeful we get an Apollo_ 09/02/14 05:53:00 PM
#421   Apollo, Why do you think something will happen this week? Dog5277 09/02/14 03:23:09 PM
#420   Hoping this week brings more trial results and Apollo_ 08/31/14 02:17:18 PM
#419   What are they good at? Raising just searching4rainbow 08/26/14 09:20:42 AM
#418   Totally agree with you stockup4it. There wasn't Dog5277 08/25/14 04:39:52 PM
#417   BAD NEWS JUST OUT intheknow1 08/25/14 03:46:59 PM
#416   That's because there wasn't that bad of news. stockup4it 08/21/14 08:00:22 PM
#415   Holy sh*t! What the hell happened? McLoweryJr 08/21/14 05:39:25 PM
#414   I haven't had time to listen yet but inversor86 08/21/14 02:27:13 PM
#413   1.) BTD and Orphan Drug status have both barkley3 08/20/14 09:39:16 PM
#412   Practical problem: If patients can't be reliably and barkley3 08/20/14 08:19:16 PM
#411   Tomorrow is huge for the future of $CYDY Apollo_ 08/19/14 10:32:33 PM
#410   So, why do you think they are doing Dog5277 08/19/14 06:01:48 PM
#409   Hopefully they can put some concerns to rest inversor86 08/19/14 01:18:26 PM
#408   Additional treatment applications for PRO140 beyond HIV? Apollo_ 08/15/14 08:39:13 PM
#407   CytoDyn Announces Webcast for Annual Shareholder Meeting Apollo_ 08/15/14 03:40:12 PM
#406   Absolutely, I'll post up a summary as soon stockup4it 08/15/14 09:25:06 AM
#405   GET THE STOCK MOVING WITH GOOD INFORMATION, OR venus1 08/14/14 11:03:47 PM
#404   Could you please post a summary of your inversor86 08/14/14 09:36:24 PM
#403   I will be going. stockup4it 08/14/14 08:59:24 PM
#402   Anyone going to the SHM? inversor86 08/14/14 03:47:13 PM
#401   Their IR guy is just a rep who inversor86 08/13/14 12:25:50 AM
#400   PRO140:potent, short-term, dose-dependent, highly significant antiviral activity Apollo_ 08/12/14 09:25:37 PM
PostSubject